ELRIG Drug Discovery 2026 has ended. This guide stays up as the record of who was there. Next: ELRIG DD 2027, Oct 19–20, 2027 in Liverpool

Universities, institutes and hospitals at ELRIG Drug Discovery 2026

Oct 14–15, 2026 London, UK ~3k attendees Website

27 universities, institutes and hospitals are at ELRIG Drug Discovery 2026 — 35 presentations on the program and 1 with a booth in the exhibit hall. Most represented: University College London (3 on the program), The Francis Crick Institute (3 on the program), Imperial College London (2 on the program). 9 of them have their own page in this guide. As of Oct 8, 2026.

All 388 organizations at ELRIG Drug Discovery 2026 →

Topic
Top represented
Showing 1–17 of 27 organizations
OrganizationELRIG Drug Discovery 2026 Attendance
Academic & healthcare
Public research university in London.
Talk
Wed Oct 14
3:45pm–4:15pm
Therapeutic application of “ready-made” base-edited CAR T cells in leukaemia
CRISPR/Cas technologies from discovery to therapeutic application
Talk
Thu Oct 15
12:40pm–1:10pm
Mindful Conversations: Building Trust with Black Communities as a Foundation for Inclusive Dementia Research
Inclusive translational approaches to accelerate equitable neuroscience drug development
Talk
Thu Oct 15
3:00pm–3:30pm
Bridging the Translation Gap: How Core Facilities Turn High‑Dimensional Cytometry Into Clinically Meaningful Outcomes
From multi-omics to clinical outcomes: Insights for drug development
Academic & healthcare
Biomedical research institute in London.
Chair
Wed Oct 14
11:15am–11:20am
Track Chair - CRISPR/Cas technologies from discovery to therapeutic application
How CRISPR gene editing is used from finding drug targets to engineering cell and gene therapies, and where it may go next.
with AstraZeneca
Talk
Wed Oct 14
11:20am–11:50am
The drugs are in the details: A microscopy-based CRISPR screen reveals unexpected vulnerabilities of a neglected parasitic disease
CRISPR/Cas technologies from discovery to therapeutic application
Academic & healthcare
London research university in science, engineering, medicine and business.
Talk
Thu Oct 15
11:55am–12:25pm
Beyond Protein Expression: Singel-Cell Spatial Protein Organization in Autoimmune Disease
From multi-omics to clinical outcomes: Insights for drug development
Talk
Thu Oct 15
3:00pm–3:30pm
Developing a Drug Pipeline for a Multi-arm Multi-stage Platform Trial in Clinical Alzheimer’s Disease
Inclusive translational approaches to accelerate equitable neuroscience drug development
Academic & healthcare
National research institute studying dementia and neurodegenerative disease through centres hosted at UK universities.
Chair
Thu Oct 15
10:50am–10:55am
Track Chair - Inclusive translational approaches to accelerate equitable neuroscience drug development
What it takes to move neurological drugs through clinical trials, from trial design and patient grouping to diverse enrolment and regulatory expectations.
with Northumbria University
Talk
Thu Oct 15
10:55am–11:25am
From High throughput Phenotypic Drug Screening to Clinical Trials: Advancing ALS/MND Therapeutics
Inclusive translational approaches to accelerate equitable neuroscience drug development
Academic & healthcare
Public research university in Cork, Ireland.
Chair
Thu Oct 15
10:50am–10:55am
Track Chair - From microbes to medicines
How microbes, including ones that cannot be grown in the lab, are mined for new drugs that tackle resistance and treatment gaps.
with University of Huddersfield
Academic & healthcare
Public research university in Edinburgh, Scotland.
Talk
Wed Oct 14
2:00pm–2:30pm
Intratarget Microdosing in the human lung to accelerate therapeutic development
Translating ideas into therapies - Navigating the challenges
Talk
Thu Oct 15
3:00pm–3:30pm
Deep Machine Learning on Chemical Synthesis
AI in medicinal chemistry
Academic & healthcare
Collegiate research university in Oxford.
Talk
Wed Oct 14
3:45pm–4:15pm
Decoding how immune receptors and extracellular vesicles build lymphocyte networks using synthetic cells, lymphoid organoids, and tumoroids
Engineering the cell microenvironment: Cell-based models for drug discovery
Talk
Thu Oct 15
11:55am–12:25pm
From Mechanism to Evidence: Cardiovascular Imaging Biomarkers and Surrogate Endpoints in Drug Development
The power of imaging in drug discovery and the clinic
Academic & healthcare
Genomics research institute near Cambridge, UK.
Talk
Wed Oct 14
2:00pm–2:30pm
A CRISPR way to understand neurodegeneration
CRISPR/Cas technologies from discovery to therapeutic application
Talk
Thu Oct 15
10:55am–11:25am
Building a tumour-derived organoid biobank: logistics and technology for multi-omic and functional screening at scale
From sample to translation: Solving the practical challenges of modern drug discovery
AU
ARUK UCL Drug Discovery Institute
London, UK
Academic & healthcare
Drug discovery institute at University College London, funded by Alzheimer's Research UK, pursuing new targets for neurodegenerative disease.
Panel
Thu Oct 15
3:30pm–4:00pm
Panel session - Who Gets to Benefit? Making Neuroscience Drug Development Truly Equitable
Inclusive translational approaches to accelerate equitable neuroscience drug development
Academic & healthcare
Research university in Wales.
Talk
Thu Oct 15
3:00pm–3:30pm
Targeted and Armed: Repurposing Adenovirus for In Situ Cancer Immunotherapy
From microbes to medicines
Academic & healthcare
Magnetic resonance centre of the University of Florence and a major NMR infrastructure for structural biology, including in-cell NMR.
Talk
Wed Oct 14
2:40pm–3:10pm
CNPEM
Campinas, Brazil
Academic & healthcare
Brazil's national research center for energy and materials, running open-access facilities including automated high-throughput and high-content screening for drug discovery.
Talk
Wed Oct 14
11:20am–11:50am
Biodiversity at Scale
Engineering the cell microenvironment: Cell-based models for drug discovery
Academic & healthcare
Oxford research institute translating science into solutions in health, food, climate and AI, including a Generative Biology Institute.
FG
Functional Genomics Centre
Cambridge, UK
Academic & healthcare
AstraZeneca and Cancer Research Horizons collaboration running CRISPR screens to find and validate cancer drug targets.
Talk
Wed Oct 14
12:20pm–12:50pm
Application of CRISPR screens for therapeutic target identification and validation in cancer drug discovery
CRISPR/Cas technologies from discovery to therapeutic application
Karolinska Institutet
Stockholm, Sweden
Talk
Thu Oct 15
2:30pm–3:00pm
Beyond Viability: Advanced Disease Models for Functional Discovery in Ovarian Cancer
The power of imaging in drug discovery and the clinic
Talk
Wed Oct 14
5:30pm–6:30pm
Early Career Professionals: Network Like A Boss
Meeting other early career professionals in speed networking rounds to build the contacts a drug discovery career depends on.
with GSK

Explore the full ELRIG Drug Discovery 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in London. Leave your work email and we’ll be in touch.

Privacy

Download the full ELRIG Drug Discovery 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from universities, institutes and hospitals

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Browse ELRIG Drug Discovery 2026 by

Exhibit hall

Not affiliated with or endorsed by ELRIG. Submit a correction